首页 > 最新文献

Canadian Journal of Ophthalmology最新文献

英文 中文
Integrating AI with tele-ophthalmology in Canada: a review. 加拿大将人工智能与远程眼科相结合:综述。
Pub Date : 2024-09-07 DOI: 10.1016/j.jcjo.2024.08.013
Michael Balas,Jonathan A Micieli,Jovi Wong
The field of ophthalmology is rapidly advancing, with technological innovations enhancing the diagnosis and management of eye diseases. Tele-ophthalmology, or the use of telemedicine for ophthalmology, has emerged as a promising solution to improve access to eye care services, particularly for patients in remote or underserved areas. Despite its potential benefits, tele-ophthalmology faces significant challenges, including the need for high volumes of medical images to be analyzed and interpreted by trained clinicians. Artificial intelligence (AI) has emerged as a powerful tool in ophthalmology, capable of assisting clinicians in diagnosing and treating a variety of conditions. Integrating AI models into existing tele-ophthalmology infrastructure has the potential to revolutionize eye care services by reducing costs, improving efficiency, and increasing access to specialized care. By automating the analysis and interpretation of clinical data and medical images, AI models can reduce the burden on human clinicians, allowing them to focus on patient care and disease management. Available literature on the current status of tele-ophthalmology in Canada and successful AI models in ophthalmology was acquired and examined using the Arksey and O'Malley framework. This review covers literature up to 2022 and is split into 3 sections: 1) existing Canadian tele-ophthalmology infrastructure, with its benefits and drawbacks; 2) preeminent AI models in ophthalmology, across a variety of ocular conditions; and 3) bridging the gap between Canadian tele-ophthalmology and AI in a safe and effective manner.
眼科领域发展迅速,技术创新提高了眼科疾病的诊断和管理水平。远程眼科,或将远程医疗用于眼科,已成为改善眼科医疗服务的一种很有前景的解决方案,尤其是对偏远地区或服务不足地区的患者而言。尽管远程眼科具有潜在的优势,但它也面临着巨大的挑战,包括需要由训练有素的临床医生对大量医疗图像进行分析和解读。人工智能(AI)已成为眼科领域的有力工具,能够协助临床医生诊断和治疗各种疾病。将人工智能模型集成到现有的远程眼科基础设施中,有可能通过降低成本、提高效率和增加获得专业护理的机会,彻底改变眼科护理服务。通过自动分析和解读临床数据和医学图像,人工智能模型可以减轻人类临床医生的负担,使他们能够专注于患者护理和疾病管理。我们利用 Arksey 和 O'Malley 框架获取并研究了有关加拿大远程眼科现状和眼科领域成功人工智能模型的现有文献。本综述涵盖截至 2022 年的文献,分为三个部分:1)加拿大现有的远程眼科基础设施及其优点和缺点;2)眼科领域杰出的人工智能模式,涵盖各种眼科疾病;3)以安全有效的方式弥合加拿大远程眼科与人工智能之间的差距。
{"title":"Integrating AI with tele-ophthalmology in Canada: a review.","authors":"Michael Balas,Jonathan A Micieli,Jovi Wong","doi":"10.1016/j.jcjo.2024.08.013","DOIUrl":"https://doi.org/10.1016/j.jcjo.2024.08.013","url":null,"abstract":"The field of ophthalmology is rapidly advancing, with technological innovations enhancing the diagnosis and management of eye diseases. Tele-ophthalmology, or the use of telemedicine for ophthalmology, has emerged as a promising solution to improve access to eye care services, particularly for patients in remote or underserved areas. Despite its potential benefits, tele-ophthalmology faces significant challenges, including the need for high volumes of medical images to be analyzed and interpreted by trained clinicians. Artificial intelligence (AI) has emerged as a powerful tool in ophthalmology, capable of assisting clinicians in diagnosing and treating a variety of conditions. Integrating AI models into existing tele-ophthalmology infrastructure has the potential to revolutionize eye care services by reducing costs, improving efficiency, and increasing access to specialized care. By automating the analysis and interpretation of clinical data and medical images, AI models can reduce the burden on human clinicians, allowing them to focus on patient care and disease management. Available literature on the current status of tele-ophthalmology in Canada and successful AI models in ophthalmology was acquired and examined using the Arksey and O'Malley framework. This review covers literature up to 2022 and is split into 3 sections: 1) existing Canadian tele-ophthalmology infrastructure, with its benefits and drawbacks; 2) preeminent AI models in ophthalmology, across a variety of ocular conditions; and 3) bridging the gap between Canadian tele-ophthalmology and AI in a safe and effective manner.","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"68 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142196813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time to pars plana vitrectomy in adults with retained lens fragments: a systematic review and meta-analysis. 成人晶状体碎片滞留者行玻璃体旁切除术的时间:系统综述和荟萃分析。
Pub Date : 2024-09-07 DOI: 10.1016/j.jcjo.2024.08.008
Michelle Lim,Irina Sverdlichenko,Elizabeth Y Wei,Andrew Mihalache,Marko M Popovic,Mohammed Alfalah,Miguel Cruz Pimentel,Rajeev H Muni,Peter J Kertes
INTRODUCTIONThis review and meta-analysis compare visual outcomes and complication risk based on the timing of pars plana vitrectomy (PPV) following cataract surgery with retained lens fragments.METHODSMEDLINE (Ovid), EMBASE, and Cochrane Library were searched between 2000 to February 2022 for studies comparing visual outcomes and complications based on time to PPV. Discrete outcomes were analyzed using a random-effects meta-analysis model on Review Manager (RevMan 5.4). The certainty of evidence of outcomes was evaluated using the Grading of Recommendations, Assessment, Development and Evaluation approach.RESULTSTen studies and 1,693 eyes were included. The incidence of patients achieving a final best-corrected visual acuity (BCVA) of >6/12 Snellen may be similar among patients receiving PPV within 1 week or after 1 week of cataract surgery (RR = 1.06, 95% CI = [0.96, 1.17], p = 0.25), and patients receiving PPV within 1 month or after 1 month of cataract surgery (RR = 1.12, 95% CI = [0.95, 1.32]; p = 0.18). Incidence of glaucoma or elevated intraocular pressure for patients may be similar among patients receiving PPV within 1 week or after 1 week of cataract surgery (RR = 1.08, 95% CI = [0.62, 1.87]; p = 0.79), and patients receiving PPV within 1 month or after 1 month of cataract surgery (RR = 0.33, 95% CI = [0.09, 1.23]; p = 0.10).CONCLUSIONIncidence of patients achieving a final BCVA of >6/12 Snellen or postoperative adverse effects was similar between patients who underwent early and late PPV following cataract surgery. However, all studies had an overall serious risk of bias, primarily because of confounding and reporting bias.
方法检索2000年至2022年2月期间的MEDLINE (Ovid)、EMBASE和Cochrane图书馆,根据PPV的时间比较视觉结果和并发症风险。使用Review Manager (RevMan 5.4)上的随机效应荟萃分析模型对离散结果进行分析。结果纳入了 10 项研究和 1,693 只眼睛。白内障手术后 1 周内或 1 周后接受 PPV 的患者(RR = 1.06,95% CI = [0.96,1.17],p = 0.25)以及白内障手术后 1 个月内或 1 个月后接受 PPV 的患者(RR = 1.12,95% CI = [0.95,1.32];p = 0.18)最终最佳矫正视力 (BCVA) >6/12 Snellen 的发生率可能相似。白内障手术后 1 周内或 1 周后接受 PPV 的患者青光眼或眼压升高的发生率可能相似(RR = 1.08,95% CI = [0.62,1.87];P = 0.79),白内障手术后 1 个月内或 1 个月后接受 PPV 的患者青光眼或眼压升高的发生率可能相似(RR = 0.结论白内障手术后早期和晚期接受 PPV 的患者最终 BCVA >6/12 Snellen 或术后不良反应的发生率相似。然而,所有研究总体上都存在严重的偏倚风险,主要原因是混杂因素和报告偏倚。
{"title":"Time to pars plana vitrectomy in adults with retained lens fragments: a systematic review and meta-analysis.","authors":"Michelle Lim,Irina Sverdlichenko,Elizabeth Y Wei,Andrew Mihalache,Marko M Popovic,Mohammed Alfalah,Miguel Cruz Pimentel,Rajeev H Muni,Peter J Kertes","doi":"10.1016/j.jcjo.2024.08.008","DOIUrl":"https://doi.org/10.1016/j.jcjo.2024.08.008","url":null,"abstract":"INTRODUCTIONThis review and meta-analysis compare visual outcomes and complication risk based on the timing of pars plana vitrectomy (PPV) following cataract surgery with retained lens fragments.METHODSMEDLINE (Ovid), EMBASE, and Cochrane Library were searched between 2000 to February 2022 for studies comparing visual outcomes and complications based on time to PPV. Discrete outcomes were analyzed using a random-effects meta-analysis model on Review Manager (RevMan 5.4). The certainty of evidence of outcomes was evaluated using the Grading of Recommendations, Assessment, Development and Evaluation approach.RESULTSTen studies and 1,693 eyes were included. The incidence of patients achieving a final best-corrected visual acuity (BCVA) of >6/12 Snellen may be similar among patients receiving PPV within 1 week or after 1 week of cataract surgery (RR = 1.06, 95% CI = [0.96, 1.17], p = 0.25), and patients receiving PPV within 1 month or after 1 month of cataract surgery (RR = 1.12, 95% CI = [0.95, 1.32]; p = 0.18). Incidence of glaucoma or elevated intraocular pressure for patients may be similar among patients receiving PPV within 1 week or after 1 week of cataract surgery (RR = 1.08, 95% CI = [0.62, 1.87]; p = 0.79), and patients receiving PPV within 1 month or after 1 month of cataract surgery (RR = 0.33, 95% CI = [0.09, 1.23]; p = 0.10).CONCLUSIONIncidence of patients achieving a final BCVA of >6/12 Snellen or postoperative adverse effects was similar between patients who underwent early and late PPV following cataract surgery. However, all studies had an overall serious risk of bias, primarily because of confounding and reporting bias.","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"72 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142196815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appointment patterns and patient perspectives in corneal telemedicine. 角膜远程医疗的预约模式和患者观点。
Pub Date : 2024-09-06 DOI: 10.1016/j.jcjo.2024.08.012
Alison Banwell,Stephanie Baxter
{"title":"Appointment patterns and patient perspectives in corneal telemedicine.","authors":"Alison Banwell,Stephanie Baxter","doi":"10.1016/j.jcjo.2024.08.012","DOIUrl":"https://doi.org/10.1016/j.jcjo.2024.08.012","url":null,"abstract":"","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142196816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Attitudes of Canadian ophthalmology residents on rural and indigenous ophthalmology education. 加拿大眼科住院医师对农村和土著眼科教育的态度。
Pub Date : 2024-09-06 DOI: 10.1016/j.jcjo.2024.08.009
Hamza Inayat,Tara Gholamian,Jillian Bertrand,Emma Hiller,Natalie Mezey,Jobanpreet Dhillon,Nishaant Bhambra,Myrna Lichter
{"title":"Attitudes of Canadian ophthalmology residents on rural and indigenous ophthalmology education.","authors":"Hamza Inayat,Tara Gholamian,Jillian Bertrand,Emma Hiller,Natalie Mezey,Jobanpreet Dhillon,Nishaant Bhambra,Myrna Lichter","doi":"10.1016/j.jcjo.2024.08.009","DOIUrl":"https://doi.org/10.1016/j.jcjo.2024.08.009","url":null,"abstract":"","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142196814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ocular screening for chronic graft-versus-host disease in patients with allogeneic hematopoietic stem cell transplant 异体造血干细胞移植患者慢性移植物抗宿主疾病的眼部筛查
Pub Date : 2024-05-01 DOI: 10.1016/j.jcjo.2024.04.005
Bryan G. Pearson, Ray S. Cortez, Karima S. Khimani, Praveena K. Gupta
{"title":"Ocular screening for chronic graft-versus-host disease in patients with allogeneic hematopoietic stem cell transplant","authors":"Bryan G. Pearson, Ray S. Cortez, Karima S. Khimani, Praveena K. Gupta","doi":"10.1016/j.jcjo.2024.04.005","DOIUrl":"https://doi.org/10.1016/j.jcjo.2024.04.005","url":null,"abstract":"","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"71 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141145696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual impairment, employment status, and reduction in income: the Canadian Longitudinal Study on Aging 视力障碍、就业状况和收入减少:加拿大老龄问题纵向研究
Pub Date : 2024-05-01 DOI: 10.1016/j.jcjo.2024.04.006
Emma Iverson, Mahadeo Sukhai, Matthew P. Quinn, M. Aubin, Ellen E. Freeman
{"title":"Visual impairment, employment status, and reduction in income: the Canadian Longitudinal Study on Aging","authors":"Emma Iverson, Mahadeo Sukhai, Matthew P. Quinn, M. Aubin, Ellen E. Freeman","doi":"10.1016/j.jcjo.2024.04.006","DOIUrl":"https://doi.org/10.1016/j.jcjo.2024.04.006","url":null,"abstract":"","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"92 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141135540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cystoid macular edema after vitrectomy and after phacovitrectomy for epiretinal membrane 玻璃体切除术后和视网膜外膜相切除术后的囊样黄斑水肿
Pub Date : 2023-12-22 DOI: 10.1016/j.jcjo.2023.11.020
Sung Who Park, Hui Kyung Kim, Moosa Hasan Zaidi, Ik Soo Byon, Ji Eun Lee, Quan Dong Nguyen

Objective

To compare the incidence of cystoid macular edema (CME) after vitrectomy and CME after phacovitrectomy in patients requiring epiretinal membrane (ERM) removal.

Design

A retrospective, comparative, interventional study.

Methods

Medical records of patients who had undergone vitrectomy or phacovitrectomy for ERM removal by a single surgeon were retrospectively reviewed. Phacovitrectomy was performed in all phakic eyes and vitrectomy was performed in all pseudophakic eyes. Increased macular thickness (IMT) was defined as an increase in macular thickness by more than 10% at the postoperative week 4 visit compared to the measurements at baseline.

Results

There were 214 and 53 eyes in the Phacovitrectomy group and the Vitrectomy group, respectively. IMT occurred in 15.4% of the Phacovitrectomy group, which was higher than the incidence of 3.8% in the Vitrectomy group (p=0.023).

Conclusions

IMT, that is suspected to be a type of CME, was not uncommon (15.4%) after phacovitrectomy in phakic eyes but was uncommon (4.8%) after vitrectomy alone in pseudophakic eyes. Irvine-Gass syndrome appears to be triggered by crystalline lens removal itself rather than intraocular surgery or surgical trauma alone.

目的比较需要切除视网膜外膜(ERM)的患者在玻璃体切割术后和虹膜切除术后囊样黄斑水肿(CME)的发生率。方法回顾性分析由一名外科医生对接受玻璃体切割术或虹膜切除术切除视网膜外膜的患者的医疗记录。所有晶状体存在的眼睛都进行了虹膜切除术,所有假性晶状体存在的眼睛都进行了玻璃体切除术。黄斑厚度增加(IMT)的定义是,术后第4周就诊时黄斑厚度比基线测量值增加10%以上。结论IMT被怀疑是CME的一种,在法氏眼球切除术后并不少见(15.4%),但在假性法氏眼球单纯玻璃体切除术后并不常见(4.8%)。Irvine-Gass 综合征似乎是由晶体摘除术本身而非眼内手术或手术创伤引发的。
{"title":"Cystoid macular edema after vitrectomy and after phacovitrectomy for epiretinal membrane","authors":"Sung Who Park, Hui Kyung Kim, Moosa Hasan Zaidi, Ik Soo Byon, Ji Eun Lee, Quan Dong Nguyen","doi":"10.1016/j.jcjo.2023.11.020","DOIUrl":"https://doi.org/10.1016/j.jcjo.2023.11.020","url":null,"abstract":"<h3>Objective</h3><p>To compare the incidence of cystoid macular edema (CME) after vitrectomy and CME after phacovitrectomy in patients requiring epiretinal membrane (ERM) removal.</p><h3>Design</h3><p>A retrospective, comparative, interventional study.</p><h3>Methods</h3><p>Medical records of patients who had undergone vitrectomy or phacovitrectomy for ERM removal by a single surgeon were retrospectively reviewed. Phacovitrectomy was performed in all phakic eyes and vitrectomy was performed in all pseudophakic eyes. Increased macular thickness (IMT) was defined as an increase in macular thickness by more than 10% at the postoperative week 4 visit compared to the measurements at baseline.</p><h3>Results</h3><p>There were 214 and 53 eyes in the Phacovitrectomy group and the Vitrectomy group, respectively. IMT occurred in 15.4% of the Phacovitrectomy group, which was higher than the incidence of 3.8% in the Vitrectomy group (p=0.023).</p><h3>Conclusions</h3><p>IMT, that is suspected to be a type of CME, was not uncommon (15.4%) after phacovitrectomy in phakic eyes but was uncommon (4.8%) after vitrectomy alone in pseudophakic eyes. Irvine-Gass syndrome appears to be triggered by crystalline lens removal itself rather than intraocular surgery or surgical trauma alone.</p>","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"75 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139028632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival and characteristics of retinopathy of prematurity in micro-premature infants 微早产儿的存活率和早产儿视网膜病变的特征
Pub Date : 2023-12-21 DOI: 10.1016/j.jcjo.2023.11.023
Kenneth T. Eng, Parampal S. Grewal, Avner Hostovsky, Amrit S. Rai, Hatim Batawi, Alaa Alali, Peter J. Kertes, Asaph Rolnitsky

Objective

To describe the risk and nature of retinopathy of prematurity (ROP) in micro-premature infants (≤26 weeks’ gestational age [GA]).

Methods

Retrospective analysis of prospectively collected data from infants born at 22–26 weeks’ GA over a 5-year period.

Results

A total of 502 infants were identified, of whom 414 survived to discharge (82.5%). The Vermont Oxford Network database documented clinical follow-up data and ROP outcomes for all 414 patients; complete ROP clinical records were available for 294 of the infants who survived (70.8%). Forty infants were born between 22 and 23 weeks’ GA (group A, 13.6%), and 254 were born between 24 and 26 weeks’ GA (group B, 86.4%). Survival for group A infants was worse than that of group B infants (66.2% vs 85.4%; p < 0.01). Survival of group A infants improved during the study period (R2 = 0.625). Overall, 59.9% of infants developed any ROP and 8.5% developed type 1 ROP. Group A infants were more likely to develop ROP (90.0% vs 48.6%; p < 0.01) and type 1 ROP (30.0% vs 5.1%; p < 0.01) than group B infants. Group A infants developed ROP at an earlier age (32 + 6 weeks vs 33 + 3 weeks; p = 0.02) and were more likely to have zone I disease on presentation (65.0% vs 20.5%; p < 0.01), but there was no difference in the corrected gestational age of peak severity of ROP (35 + 2 weeks vs 34 + 5 weeks; p = 0.36).

Conclusion

The most premature infants, born at 22–23 weeks’ GA, develop ROP at an earlier age, are more likely to present with posterior disease, and have a high risk of disease requiring treatment.

方法回顾性分析前瞻性收集的数据,这些数据来自 5 年内出生时胎龄在 22-26 周的婴儿。佛蒙特州牛津网络数据库记录了所有 414 名患者的临床随访数据和 ROP 后果;294 名存活婴儿(70.8%)有完整的 ROP 临床记录。40 名婴儿出生时的胎龄为 22-23 周(A 组,13.6%),254 名婴儿出生时的胎龄为 24-26 周(B 组,86.4%)。A 组婴儿的存活率低于 B 组婴儿(66.2% vs 85.4%;P < 0.01)。在研究期间,A 组婴儿的存活率有所提高(R2 = 0.625)。总体而言,59.9%的婴儿患上了任何一种视网膜病变,8.5%患上了1型视网膜病变。与 B 组婴儿相比,A 组婴儿更容易患上 ROP(90.0% vs 48.6%;p <;0.01)和 1 型 ROP(30.0% vs 5.1%;p <;0.01)。A 组婴儿发生 ROP 的年龄更早(32 + 6 周 vs 33 + 3 周;p = 0.02),更有可能在发病时患有 I 区疾病(65.0% vs 20.5%;p < 0.01),但 ROP 严重程度达到峰值的校正胎龄没有差异(35 + 2 周 vs 34 + 5 周;p = 0.36)。结论22-23周出生的早产儿罹患视网膜病变的年龄较早,更有可能出现后发疾病,且需要治疗的风险较高。
{"title":"Survival and characteristics of retinopathy of prematurity in micro-premature infants","authors":"Kenneth T. Eng, Parampal S. Grewal, Avner Hostovsky, Amrit S. Rai, Hatim Batawi, Alaa Alali, Peter J. Kertes, Asaph Rolnitsky","doi":"10.1016/j.jcjo.2023.11.023","DOIUrl":"https://doi.org/10.1016/j.jcjo.2023.11.023","url":null,"abstract":"<h3>Objective</h3><p>To describe the risk and nature of retinopathy of prematurity (ROP) in micro-premature infants (≤26 weeks’ gestational age [GA]).</p><h3>Methods</h3><p>Retrospective analysis of prospectively collected data from infants born at 22–26 weeks’ GA over a 5-year period.</p><h3>Results</h3><p>A total of 502 infants were identified, of whom 414 survived to discharge (82.5%). The Vermont Oxford Network database documented clinical follow-up data and ROP outcomes for all 414 patients; complete ROP clinical records were available for 294 of the infants who survived (70.8%). Forty infants were born between 22 and 23 weeks’ GA (group A, 13.6%), and 254 were born between 24 and 26 weeks’ GA (group B, 86.4%). Survival for group A infants was worse than that of group B infants (66.2% vs 85.4%; <em>p</em> &lt; 0.01). Survival of group A infants improved during the study period (<em>R</em><sup>2</sup> = 0.625). Overall, 59.9% of infants developed any ROP and 8.5% developed type 1 ROP. Group A infants were more likely to develop ROP (90.0% vs 48.6%; <em>p</em> &lt; 0.01) and type 1 ROP (30.0% vs 5.1%; <em>p</em> &lt; 0.01) than group B infants. Group A infants developed ROP at an earlier age (32 + 6 weeks vs 33 + 3 weeks; <em>p</em> = 0.02) and were more likely to have zone I disease on presentation (65.0% vs 20.5%; <em>p</em> &lt; 0.01), but there was no difference in the corrected gestational age of peak severity of ROP (35 + 2 weeks vs 34 + 5 weeks; <em>p</em> = 0.36).</p><h3>Conclusion</h3><p>The most premature infants, born at 22–23 weeks’ GA, develop ROP at an earlier age, are more likely to present with posterior disease, and have a high risk of disease requiring treatment.</p>","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139028623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient perspectives on ocular oncology care at hybrid telehealth satellite offices 患者对混合远程医疗卫星办公室眼部肿瘤治疗的看法
Pub Date : 2023-12-21 DOI: 10.1016/j.jcjo.2023.11.005
Charlotte N. Shields, Chenab K. Khakh, G. Brandon Caudill, Carol L. Shields

Objective

To assess patient satisfaction with the hybrid telehealth model in patients undergoing follow-up care in ocular oncology.

Design

Retrospective survey study.

Participants

All patients who visited 1 of 2 satellite telehealth offices between July 2021 and October 2022 for their follow-up ocular oncology appointment.

Methods

A 13-question online survey was completed for outcome measures of patient demographics, patient satisfaction with the satellite offices, and overall patient experience with telehealth.

Results

The survey response rate was 32% (203 of 632). The mean patient age was 65 years (median, 65 years), and 119 patients (58%) were female. A comparison (suburban satellite vs urban in-person office) revealed that the suburban satellite office had less difficulty in travel (3% vs 47%; p < 0.001) and less time commitment (<1 hour) for travel to the office (58% vs 23%; p < 0.001). On a scale (i.e., poor, fair, good, or excellent), the percentage of patients reported the following parameters as good or excellent: ease of finding satellite office (95%), check-in (94%), and time spent waiting for the doctor (72%). On a scale (i.e., extremely dissatisfied to extremely satisfied), the percentage of patients reported being extremely satisfied to the following parameters: the staff (81%) and the office overall (65%). Most patients (90%) would use this telehealth model for future visits (p < 0.0001), and 86% would recommend it to a friend (p < 0.0001).

Conclusion

In this study on a hybrid telehealth satellite office model for ocular oncology follow-up examinations, patient satisfaction was high, most patients would use this form of examination in the future.

所有在 2021 年 7 月至 2022 年 10 月期间前往 2 个卫星远程医疗办公室中的 1 个办公室进行眼部肿瘤随访的患者。患者平均年龄为 65 岁(中位数为 65 岁),119 名患者(58%)为女性。通过比较(郊区卫星办公室与市区亲诊办公室)发现,郊区卫星办公室的出行难度较小(3% vs 47%; p <0.001),前往办公室所需的时间(<1 小时)也较少(58% vs 23%; p <0.001)。根据评分标准(即 "差"、"一般"、"好 "或 "优"),有一定比例的患者将以下参数评为 "好 "或 "优":找到卫星办公室的难易程度(95%)、办理登记手续的难易程度(94%)以及等待医生的时间(72%)。根据评分标准(即从非常不满意到非常满意),表示对以下参数非常满意的患者比例为:工作人员(81%)和诊所整体(65%)。大多数患者(90%)会在今后就诊时使用这种远程医疗模式(p <0.0001),86%的患者会向朋友推荐这种模式(p <0.0001)。
{"title":"Patient perspectives on ocular oncology care at hybrid telehealth satellite offices","authors":"Charlotte N. Shields, Chenab K. Khakh, G. Brandon Caudill, Carol L. Shields","doi":"10.1016/j.jcjo.2023.11.005","DOIUrl":"https://doi.org/10.1016/j.jcjo.2023.11.005","url":null,"abstract":"<h3>Objective</h3><p>To assess patient satisfaction with the hybrid telehealth model in patients undergoing follow-up care in ocular oncology.</p><h3>Design</h3><p>Retrospective survey study.</p><h3>Participants</h3><p>All patients who visited 1 of 2 satellite telehealth offices between July 2021 and October 2022 for their follow-up ocular oncology appointment.</p><h3>Methods</h3><p>A 13-question online survey was completed for outcome measures of patient demographics, patient satisfaction with the satellite offices, and overall patient experience with telehealth.</p><h3>Results</h3><p>The survey response rate was 32% (203 of 632)<em>.</em> The mean patient age was 65 years (median, 65 years), and 119 patients (58%) were female. A comparison (suburban satellite vs urban in-person office) revealed that the suburban satellite office had less difficulty in travel (3% vs 47%; <em>p</em> &lt; 0.001) and less time commitment (&lt;1 hour) for travel to the office (58% vs 23%; <em>p</em> &lt; 0.001). On a scale (i.e., poor, fair, good, or excellent), the percentage of patients reported the following parameters as good or excellent: ease of finding satellite office (95%), check-in (94%), and time spent waiting for the doctor (72%). On a scale (i.e., extremely dissatisfied to extremely satisfied), the percentage of patients reported being extremely satisfied to the following parameters: the staff (81%) and the office overall (65%). Most patients (90%) would use this telehealth model for future visits (<em>p</em> &lt; 0.0001), and 86% would recommend it to a friend (<em>p</em> &lt; 0.0001).</p><h3>Conclusion</h3><p>In this study on a hybrid telehealth satellite office model for ocular oncology follow-up examinations, patient satisfaction was high, most patients would use this form of examination in the future.</p>","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139028664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient perspectives on ocular oncology care at hybrid telehealth satellite offices 患者对混合远程医疗卫星办公室眼部肿瘤治疗的看法
Pub Date : 2023-12-01 DOI: 10.1016/j.jcjo.2023.11.005
Charlotte N. Shields, Chenab K. Khakh, G. B. Caudill, Carol L. Shields
{"title":"Patient perspectives on ocular oncology care at hybrid telehealth satellite offices","authors":"Charlotte N. Shields, Chenab K. Khakh, G. B. Caudill, Carol L. Shields","doi":"10.1016/j.jcjo.2023.11.005","DOIUrl":"https://doi.org/10.1016/j.jcjo.2023.11.005","url":null,"abstract":"","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"246 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139015694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Canadian Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1